Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Carbon Monoxide for Severe PAH
NCT01523548Phase 2Withdrawn
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2012
- Primary completion
- Dec 2018
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon monoxide in pulmonary arterial hypertension (PAH), sponsored by University of Illinois Chicago. Planned start Jul 2012; status: withdrawn.
02
Drugs
Carbon monoxide
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01523548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523548.